Want to see HK:1093 full AI Analyst Report?
Total Valuation
CSPC Pharmaceutical Group has a market cap or net worth of HK$106.29B. The enterprise value is HK$61.07K.
Market CapHK$106.29B
Enterprise ValueHK$61.07K
Share Statistics
CSPC Pharmaceutical Group has 11,522,452,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,522,452,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CSPC Pharmaceutical Group’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.43%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)8.43%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.36M
Profits Per Employee203.03K
Employee Count18,626
Asset Turnover0.54
Inventory Turnover2.82
Valuation Ratios
The current PE Ratio of CSPC Pharmaceutical Group is 12.2. CSPC Pharmaceutical Group’s PEG ratio is -1.94.
PE Ratio12.2
PS Ratio3.80
PB Ratio2.90
Price to Fair Value2.90
Price to FCF24.15
Price to Operating Cash Flow32.63
PEG Ratio-1.94
Income Statement
In the last 12 months, CSPC Pharmaceutical Group had revenue of 25.33B and earned 3.78B in profits. Earnings per share was 0.33.
Revenue25.33B
Gross Profit16.62B
Operating Income3.87B
Pretax Income4.68B
Net Income3.78B
EBITDA5.24B
Earnings Per Share (EPS)0.33
Cash Flow
In the last 12 months, operating cash flow was 2.76B and capital expenditures -766.69M, giving a free cash flow of 2.00B billion.
Operating Cash Flow2.76B
Free Cash Flow2.00B
Free Cash Flow per Share0.17
Dividends & Yields
CSPC Pharmaceutical Group pays an annual dividend of HK$0.15, resulting in a dividend yield of 3.14%
Dividend Per ShareHK$0.15
Dividend Yield3.14%
Payout Ratio91.07%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change-10.86%
50-Day Moving Average8.39
200-Day Moving Average8.39
Relative Strength Index (RSI)57.08
Average Volume (3m)94.53M
Important Dates
CSPC Pharmaceutical Group upcoming earnings date is Nov 13, 2026, TBA (Confirmed).
Last Earnings DateAug 20, 2026
Next Earnings DateNov 13, 2026
Ex-Dividend Date―
Financial Position
CSPC Pharmaceutical Group as a current ratio of 2.19, with Debt / Equity ratio of 1.73%
Current Ratio2.19
Quick Ratio1.88
Debt to Market Cap<0.01
Net Debt to EBITDA-1.04
Interest Coverage Ratio102.89
Taxes
In the past 12 months, CSPC Pharmaceutical Group has paid 907.61M in taxes.
Income Tax907.61M
Effective Tax Rate0.19
Enterprise Valuation
CSPC Pharmaceutical Group EV to EBITDA ratio is 17.33, with an EV/FCF ratio of 22.78.
EV to Sales3.59
EV to EBITDA17.33
EV to Free Cash Flow22.78
EV to Operating Cash Flow15.40
Balance Sheet
CSPC Pharmaceutical Group has HK$18.48B in cash and marketable securities with HK$652.37M in debt, giving a net cash position of HK$17.83B billion.
Cash & Marketable SecuritiesHK$18.48B
Total DebtHK$652.37M
Net CashHK$17.83B
Net Cash Per ShareHK$1.55
Tangible Book Value Per ShareHK$2.76
Margins
Gross margin is 71.86%, with operating margin of 15.27%, and net profit margin of 14.93%.
Gross Margin71.86%
Operating Margin15.27%
Pretax Margin18.49%
Net Profit Margin14.93%
EBITDA Margin20.69%
EBIT Margin15.27%
Analyst Forecast
The average price target for CSPC Pharmaceutical Group is HK$13.12, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$13.12
Price Target Upside37.82% Upside
Analyst ConsensusStrong Buy
Analyst Count13
Revenue Growth Forecast25.21%
EPS Growth Forecast103.93%